NSE · CORONA
CORONA Remedies Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#524
of 5,096 stocks
▼ 221W
Peak #502 · 21 Sep 2026
CORONA Remedies Limited is a midcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, generates a high return on equity, and remains firmly promoter-controlled, with promoters holding 69%.
Market Cap
12,557.98 Cr
P/E Ratio
67.83
P/B Ratio
16.81
ROE
24.79%
ROCE
31.54%
Dividend Yield
0.49%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 422.43 Cr | 353.09 Cr | 342.42 Cr | 361.13 Cr |
| Net Profit | 60.11 Cr | 45.33 Cr | 41.27 Cr | 52.32 Cr |
| EPS | 9.83 | 7.41 | 6.75 | 8.55 |
| Operating Profit | 83.04 Cr | 55.84 Cr | 75.95 Cr | 71.54 Cr |
Shareholding pattern
Promoter
69.00%
Public
31.00%
Mutual fund holdings
₹1,473.57
Cr total
30
Schemes
11
Fund Houses
₹1,473.57 Cr
Total Exposure
Invesco Mutual Fund₹633.60 Cr (43.0%)
HDFC Mutual Fund₹513.95 Cr (34.9%)
Aditya Birla Sun Life Mutual Fund₹120.27 Cr (8.2%)
WhiteOak Capital Mutual Fund₹111.56 Cr (7.6%)
Kotak Mahindra Mutual Fund₹56.74 Cr (3.9%)
Others₹37.46 Cr (2.5%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 19 Jun 2026 | Dividend | Dividend - Rs 10 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.